Concerning COVID-19 cases in India, scientists say: "There is no new variation or serious illness observed."

 India has also started to see an increase in infections, especially in Kerala, Tamil Nadu, Mumbai, Chennai, and Ahmedabad, after Singapore and Hong Kong had a surge in Covid-19 cases.

Experts report a modest increase in COVID cases in India, but no new variety or serious sickness.

Over the past week, there has been a minor increase in Covid-19 instances in nine states in India, which is comparable to what has happened in Southeast Asia. Experts stress that there are still few cases in India and that no concerning patterns or novel forms of worry have been found thus far.

India has also started to see an increase in infections, especially in Kerala, Tamil Nadu, Mumbai, Chennai, and Ahmedabad, after Singapore and Hong Kong had a surge in Covid-19 cases. While the overall case count remains relatively low compared to previous waves, health authorities are maintaining close surveillance of the evolving situation.

Experts speculate that since many people with respiratory symptoms choose not to get tested for COVID-19, the little increase in India may not fully reflect the actual number of cases. However, there is no proof that the virus has changed to produce more serious illness. Additionally, they point out that rather than representing a true lack of infections, the "zero" current cases reported in a number of states may be the result of inadequate testing.

Numerous offspring of the omicron variety, which swept the world in 2021–2022, are mostly to blame for the recent spike in cases in Hong Kong, Singapore, and Thailand. According to microbiologists tracking the virus's evolution, unless the virus experiences a substantial evolutionary shift, significant changes in infection patterns or severity are unlikely.

NB.1.8.1, a hybrid of XDV and JN.1, is the variation found in Hong Kong. "JN.1 has evolved from BA.2, and XDV has evolved from XBB," the Telegraph said Rajesh Karyakarte, professor and director of microbiology at BJ Medical College in Pune.

All are variations of omicrons that have previously been widely used in India, like XBB or JN.1. We don't anticipate that hospitalization trends will change significantly as a result of these derivatives. The immunity has been aided by our high vaccination and natural infection rates.